======= KIN ======= == Gene Information == * **Official Symbol**: KIN * **Official Name**: Kin17 DNA and RNA binding protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=22944|22944]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60870|O60870]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KIN&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIN|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601720|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in DNA replication and the cellular response to DNA damage. May participate in DNA replication factories and create a bridge between DNA replication and repair mediated by high molecular weight complexes. May play a role in illegitimate recombination and regulation of gene expression. May participate in mRNA processing. Binds, in vitro, to double-stranded DNA. Also shown to bind preferentially to curved DNA in vitro and in vivo (By similarity). Binds via its C-terminal domain to RNA in vitro. {ECO:0000250|UniProtKB:Q8K339, ECO:0000269|PubMed:11880372, ECO:0000269|PubMed:12359749, ECO:0000269|PubMed:12754299, ECO:0000269|PubMed:12853634, ECO:0000269|PubMed:15831485, ECO:0000269|PubMed:17045609}. |Kin17 mid| |double-stranded DNA binding| |nuclear matrix| |DNA replication| |DNA recombination| |mRNA processing| |DNA repair| |protein-containing complex| |intracellular membrane-bounded organelle| |mRNA metabolic process| |viral process| |DNA metabolic process| |cellular response to DNA damage stimulus| |symbiotic process| |interspecies interaction between organisms| |RNA processing| |RNA binding| |DNA binding| |RNA metabolic process| |cellular response to stress| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|-1.83| |[[:results:exp453|B02 10μM R08 exp453]]|1.71| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.83| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|1.86| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.88| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|1.89| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|2.02| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|2.19| ^Gene^Correlation^ |[[:human genes:p:psma6|PSMA6]]|0.435| |[[:human genes:p:psmb4|PSMB4]]|0.424| |[[:human genes:p:polr2j3|POLR2J3]]|0.42| |[[:human genes:g:golga6l3|GOLGA6L3]]|0.413| |[[:human genes:c:copg1|COPG1]]|0.411| |[[:human genes:c:cdc5l|CDC5L]]|0.4| Global Fraction of Cell Lines Where Essential: 582/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|19/28| |blood|21/28| |bone|22/26| |breast|20/33| |central nervous system|45/56| |cervix|3/4| |colorectal|16/17| |esophagus|11/13| |fibroblast|1/1| |gastric|14/16| |kidney|12/21| |liver|9/20| |lung|60/75| |lymphocyte|15/16| |ovary|22/26| |pancreas|19/24| |peripheral nervous system|14/16| |plasma cell|15/15| |prostate|1/1| |skin|23/24| |soft tissue|6/9| |thyroid|2/2| |upper aerodigestive|18/22| |urinary tract|20/29| |uterus|4/5| == Essentiality in NALM6 == * **Essentiality Rank**: 745 * **Expression level (log2 read counts)**: 5.18 {{:chemogenomics:nalm6 dist.png?nolink |}}